HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y K Hayashi Selected Research

Frontotemporal Dementia (Semantic Dementia)

3/2012Characterization of the Asian myopathy patients with VCP mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y K Hayashi Research Topics

Disease

4Muscular Dystrophies (Muscular Dystrophy)
09/2007 - 08/2001
3Muscular Diseases (Myopathy)
03/2012 - 01/2002
3Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
12/2007 - 08/2001
2Distal Myopathies (Distal Muscular Dystrophy)
01/2018 - 01/2002
2Scleroatonic muscular dystrophy
09/2007 - 02/2004
2Miyoshi myopathy
10/2004 - 08/2001
2type 2B Limb-girdle muscular dystrophy
10/2004 - 08/2001
1Myofibrillar Myopathy
01/2018
1Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
01/2018
1Nerve Degeneration
01/2018
1Hemorrhage
11/2013
1Congenital Structural Myopathies (Centronuclear Myopathy)
11/2013
1Peliosis Hepatis
11/2013
1Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia
03/2012
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
03/2012
1Osteitis Deformans (Paget's Disease of Bone)
03/2012
1Vacuolar myopathy
03/2012
1Frontotemporal Dementia (Semantic Dementia)
03/2012
1Central Core Myopathy (Central Core Disease)
01/2008
1With Uniform Type 1 Fiber Congenital Neuromuscular Disease
01/2008
1Neuromuscular Diseases (Neuromuscular Disease)
01/2008
1Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy)
12/2007
1X-Linked Myopathy with Excessive Autophagy
10/2005
1Progeria (Hutchinson Gilford Syndrome)
10/2005
1Nonaka type Distal myopathy
10/2005
1Cardiomyopathies (Cardiomyopathy)
10/2005
1Lipodystrophy
10/2005
1Dysferlinopathy
10/2004
1Type 2I Limb-Girdle Muscular Dystrophy
04/2003
1Muscular Atrophy (Muscle Atrophy)
01/2002
1Sarcoglycanopathies
12/2001
1Limb-girdle muscular dystrophy type 2A
12/2001
1Type 1C Limb-Girdle Muscular Dystrophy
08/2001
1Walker-Warburg Syndrome
07/2001
1Oculopharyngeal Muscular Dystrophy
05/2001
1Necrosis
05/2001
1merosin negative Muscular dystrophy congenital
05/2001

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
12/2007 - 05/2001
3CollagenIBA
09/2007 - 02/2004
3DysferlinIBA
10/2004 - 08/2001
2Lamin Type A (Lamin A)IBA
12/2007 - 10/2005
2Caveolin 3IBA
01/2002 - 08/2001
1Protein AggregatesIBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2018
1Small Heat-Shock ProteinsIBA
01/2018
1Valosin Containing ProteinIBA
03/2012
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2008
1emerinIBA
12/2007
1Complement Membrane Attack Complex (Membrane Attack Complex)IBA
10/2005
1CalciumIBA
10/2005
1Phosphotransferases (Kinase)IBA
10/2005
1Sarcoglycans (beta Sarcoglycan)IBA
12/2001
1CalpainIBA
12/2001
1AntibodiesIBA
12/2001
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2001
1Dystroglycans (Dystroglycan)IBA
07/2001
1Poly(A)-Binding Protein IIIBA
05/2001
1polyalanineIBA
05/2001
1Poly(A)-Binding Proteins (Poly(A)-Binding Protein)IBA
05/2001
1Laminin (Merosin)IBA
05/2001

Therapy/Procedure

1Artificial Respiration (Mechanical Ventilation)
11/2013